Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
Tags:
cancer, CAR-T, Amgen, Celgene, Bluebird Bio, Novartis, Kite Pharma, Pfizer, Cellectis, Juno Therapeutics
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Tags:
Sanofi, Regeneron, Amgen, alirocumab, evolocumab, PCSK9 inhibitors
Novartis psoriasis drug approval could upend market
Medical Marketing and Media
Thu, 01/22/15 - 09:55 am
Tags:
Novartis, psoriasis, Cosentyx, Amgen, Stelara, Enbrel
Drug companies find common ground over Colorado's 'biosimilars' legislation
Bizjournals.com
Wed, 01/21/15 - 09:42 am
Tags:
Colorado, biologics, generics, Amgen, Sandoz
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
Amgen closed Friday up 4.29% on the back of positive Phase II PEAK results for its mCRC drug, Vectibix
Bidness Etc.
Sat, 01/17/15 - 04:01 pm
Tags:
Amgen, Vectibix, metastatic colorectal cancer, mCRC
Kite Pharma/Amgen: A Strong Combination
Seeking Alpha
Thu, 01/15/15 - 05:50 pm
Tags:
Kite Pharma, Amgen, Juno Therapeutics, Bellicum, Ziopharm, CAR-T
After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
Bloomberg
Wed, 01/14/15 - 10:08 am
Tags:
hepatitis C, Express Scripts, Regeneron, Amgen, PCSK9 inhibitor
Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting
TheStreet.com
Tue, 01/13/15 - 04:46 pm
Tags:
Express Scripts, drug pricing, Amgen, Regeneron
Big Pharma threatens to sue U.K. fund as officials nix Novartis, Sanofi and Eisai meds
Fierce Pharma
Fri, 01/9/15 - 09:58 am
Tags:
UK, Novartis, Sanofi, Eisai, Roche, Pfizer, Amgen
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Tags:
Amgen, Regeneron, evolocumab, alirocumab, Alexion, asfotase alfa, Novartis, LCZ696, Pfizer, palbociclib
FDA panel recommends approval for first generic biotech drug
Marketwatch
Wed, 01/7/15 - 06:49 pm
Tags:
FDA, advisory panels, biosimilars, Neupogen, Amgen, Novartis, Sandoz
Amarin: Kowa Co-Promotion Agreement May Be Boosting Sales
Seeking Alpha
Mon, 01/5/15 - 10:12 am
Tags:
Amgen, Kowa, Vascepa
Amgen and Kite Pharma in cancer immunotherapy pact
Marketwatch
Mon, 01/5/15 - 10:09 am
Tags:
Amgen, Kite Pharma, cancer immunotherapy
FDA staff recommends Novartis copy of Amgen's Neupogen
Yahoo/Reuters
Mon, 01/5/15 - 09:29 am
Tags:
FDA, Amgen, Novartis, Neupogen, biosimilars, breast cancer, Zarzio, chemotheraphy-induced neutropenia
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:23 pm
Tags:
Actavis, Celgene, Amgen, AbbVie, Gilead Sciences, Eli Lilly, Novartis, AstraZeneca, Merck, JNJ, Biogen Idec, Novo Nordisk, Roche, Bristol-Myers Squibb, Pfizer, GSK, Sanofi
3 Pharma Giants Growing Significantly Faster Than GlaxoSmithKline PLC
Motley Fool
Fri, 12/26/14 - 10:26 pm
Tags:
GSK, Amgen, Celgene, JNJ
A new era of immuno-oncology has arrived
Fierce Biotech
Fri, 12/26/14 - 10:17 am
Tags:
immuno-oncology, Merck, Keytruda, Bristol-Myers Squibb, Opdivo, Roche, Amgen, AstraZeneca
Gilead Sciences (GILD) Is Hurting, And So Is The Rest Of The Biotech Sector
Bidness Etc.
Wed, 12/24/14 - 09:38 am
Tags:
Gilead Sciences, biotech, AbbVie, Amgen, Express Scripts
Amgen slaps record-breaking $178K price on rare leukemia drug Blincyto
Fierce Pharma Marketing
Mon, 12/22/14 - 01:10 pm
Tags:
Amgen, Blincyto, acute lymphoblastic leukemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.